NLRP3 and Alzheimer disease: Based on these results, the authors conclude that introducing therapeutic treatments targeting the NLRP3 inflammasome may have a beneficial effect on patients with Alzheimer's disease as NLRP3 activation may contribute to the pathogenesis of Alzheimer's disease in humans.